Ex-Mod­er­na com­mer­cial leader lands at Cel­sion as CEO; Schwan song: Chang­ing of the guard at Roche to take ef­fect next year

Less than 12 months in­to her job lead­ing the com­mer­cial roll­out of one of the world’s biggest-sell­ing biotech prod­ucts, Mod­er­na’s Covid-19 vac­cine, Corinne Le Goff de­part­ed the house­hold name in De­cem­ber 2021, but her fu­ture in the in­dus­try is just now com­ing in­to clear view.

The more than 30-year in­dus­try vet­er­an — whose posts have run the gamut across Pfiz­er, Sanofi, Mer­ck, Roche and Am­genis now CEO and pres­i­dent of Cel­sion, which it­self is po­ten­tial­ly look­ing to get in­to the SARS-CoV-2 vac­cine land­scape, al­beit way lat­er than her pre­vi­ous em­ploy­er.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.